111 Capital Biogen Inc. Transaction History
111 Capital
- $518 Billion
- Q1 2025
A detailed history of 111 Capital transactions in Biogen Inc. stock. As of the latest transaction made, 111 Capital holds 5,620 shares of BIIB stock, worth $721,551. This represents 0.15% of its overall portfolio holdings.
Number of Shares
5,620Holding current value
$721,551% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,024Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.19 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.05 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.87 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$950 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$600 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...